Cargando…
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer cases are detected in early and potentially curable stages, despite the COVID-19 pandemic possibly having impacted the...
Autores principales: | Ayala de la Peña, Francisco, Antolín Novoa, Silvia, Gavilá Gregori, Joaquín, González Cortijo, Lucía, Henao Carrasco, Fernando, Martínez Martínez, María Teresa, Morales Estévez, Cristina, Stradella, Agostina, Vidal Losada, María Jesús, Ciruelos, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425528/ https://www.ncbi.nlm.nih.gov/pubmed/37326826 http://dx.doi.org/10.1007/s12094-023-03215-4 |
Ejemplares similares
-
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
por: Garcia-Saenz, Jose Angel, et al.
Publicado: (2023) -
Correction to: SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
por: Garcia-Saenz, Jose Angel, et al.
Publicado: (2023) -
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
por: Chacón López-Muñiz, J. I., et al.
Publicado: (2019) -
SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
por: Serrano, César, et al.
Publicado: (2023) -
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022)
por: Segura, Pedro Pérez, et al.
Publicado: (2023)